Hubei Goto Biopharm Group Co., Ltd. Stock: price and insider trades · China
共同药业
Hubei Goto Biopharm Group Co., Ltd.: what insiders have been doing
This page follows insider dealings at Hubei Goto Biopharm Group Co., Ltd. as filed with SSE / SZSE (CSRC), a company from the Health Care sector. No insider at Hubei Goto Biopharm Group Co., Ltd. has published a filing in the past twelve months. The most recent one dates from 17 May 2024.
Our records for Hubei Goto Biopharm Group Co., Ltd. go back to 2024, with no purchases and 2 sales on the open market in total.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About Hubei Goto Biopharm Group Co., Ltd.
共同药业 is a company specializing in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the development and production of innovative medications.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
